06821 ASYMCHEM
- 59.900
- -0.100-0.17%
ASYMCHEM News
China-Based Asymchem Laboratories Will Operate Former Pfizer Manufacturing Facility in UK
By Adriano Marchese Asymchem Laboratories (TianJin) said it will operate the former small molecule active pharmaceutical pilot plant that belonged to Pfizer UK, expanding its manufacturing footprint
Asymchem Laboratories Maintains Stable Share Count
Gloria Ying (06821.HK) spent 24.993 million yuan to buy back 308,700 A shares on May 21
On May 21, GLONGHUI (06821.HK) issued an announcement. On May 21, 2024, it spent RMB 24.993 million to repurchase 308,700 A shares at a repurchase price of RMB 80.41-81.35 per share.
Changes in Hong Kong stocks | CRO concept stocks collectively declined, and many Federal Reserve officials Fangying Pharmaceutical Outsourcing began to adjust business in the US
The Zhitong Finance App learned that CRO concept stocks were collectively lower. As of press release, Kingsley Biotech (01548) fell 4.77% to 11.58 yuan; Gloria Ying (06821) fell 4.27% to 61.65 yuan; Kanglong Chemical (03759) fell 3.65% to 11.08 yuan; Pharmaceuticals (02359) fell 3.46% to HK$39.1; Tiger Pharmaceuticals (03347) fell 3.35% to HK$34.6. According to the news, a number of Federal Reserve officials said in their Monday speech that more progress is needed on the inflation issue before interest rate cuts can be obtained
Gloria Ying (06821.HK) spent 29.2832 million yuan to buy back 356,900 A shares on May 20
On May 20, Ge Longhui (06821.HK) issued an announcement. On May 20, 2024, it spent RMB 29.2832 million to repurchase 356,900 A shares at a repurchase price of 81.44-82.2 yuan per share.
A record high! The total number of clinical trials exceeded 4,000 in 2023
According to the report, in 2023, the total number of clinical trials registered on the drug clinical trial registration and information disclosure platform surpassed 4,000 for the first time, reaching 4,300 (in terms of CTR), the highest total number of registrations in history, an increase of 26.1% over the total number of registrations in 2022.
Changes in Hong Kong stocks | CRO concept stocks are generally weakening, and many companies have responded once again by overwhelmingly passing the new US Biosafety Act
The Zhitong Finance App learned that CRO concept stocks have generally weakened. As of press release, Tiger Pharmaceuticals (03347) fell 3.3% to HK$35.15; Kingsley Biotech (01548) fell 1.44% to $12.28; Pharmaceutical Kangde (02359) fell 1.21% to $40.7; and Gloria Ying (06821) fell 0.94% to $63.55. According to the news, on the morning of May 15, local time, the US House of Representatives passed the new “Biosafety Act” with a 40-1 vote in a subordinate committee hearing. The new version of the Act requires the companies involved to have existing contracts/products
ASYMCHEM To Go Ex-Dividend On June 13th, 2024 With 1.98489 HKD Dividend Per Share
May 17th - $ASYMCHEM(06821.HK)$ is trading ex-dividend on June 13th, 2024. Shareholders of record on June 14th, 2024 will receive 1.98489 HKD dividend per share. The ex-dividend date is June 13th,
Gloria Ying (06821) will pay a final dividend of $18 for every 10 shares
According to the Zhitong Finance App, Gloria Ying (06821) announced that the company will pay a final dividend of RMB 18 for every 10 shares for the year ended December 31, 2023.
凱萊英：2023年股東週年大會通告
Gloria Ying (06821.HK) spent 498.14 million yuan to buy back 599,600 A shares on May 13
Glonghui, May 13 | Gloria Ying (06821.HK) announced that it spent 498.14 million yuan to buy back 599,600 A shares on May 13.
Gloria Ying (06821) spent about 49.9972 million yuan to buy back 594,000 shares on May 8
Gloria Eng (06821) announced that the company spent approximately RMB 4999.72 on May 8, 2024...
Gloria Ying (06821.HK) spent 49.97 million yuan to buy back 594,000 A shares on May 8
Glonghui, May 8 | Gloria Ying (06821.HK) announced that it spent 49.97 million yuan to buy back 594,000 A shares on May 8.
Gloria Ying (06821.HK) spent 21.5957 million yuan to buy back 252,900 A shares on May 7
Glonghui, May 7 | Gloria Ying (06821.HK) announced that on May 7, 2024, it spent 21.5957 million yuan to buy back 252,900 A shares.
Gloria Ying (06821) participated in the investment fund to complete business registration
Zhitong Finance App News, Gloria Ying (06821) issued an announcement. The company held the 50th meeting of the 4th board of directors on April 29, 2024 to review and pass the “Proposal on Wholly-owned Subsidiaries to Participate in Investment Funds and Related Transactions”, agreeing to invest 30 million yuan as a wholly-owned subsidiary Gloria Life Science Technology (Tianjin) as a limited partner with Tianjin Xinyin Hengze Management Consulting Partnership (Limited Partnership), Haizunchuang (Tianjin) Enterprise Management Consulting Partnership (Limited Partnership), Tianjin Haihe Industrial Fund Partnership Limited (Limited Partnership) Partnership), Tianjin Eco-City State-owned
Gloria Ying (002821.SZ): 2.02% of shares have been repurchased cumulatively
Glonghui, May 6, 丨 Gloria Ying (002821.SZ) announced that as of April 30, 2024, the total number of shares repurchased by the company through centralized bidding through a special securities account was 6,898,369 shares, accounting for 2.0175% of the company's total A share capital. The highest transaction price was 10.2.00 yuan/share, and the minimum transaction price was 75.53 yuan/share. The total amount paid was 578 million yuan (excluding transaction fees).
Changes in Hong Kong stocks | CRO concept stocks fell across the board, Yakming Kangde (02359) fell more than 7%, leading the decline, and the company's profit margin for the first quarter fell short of expectations
CRO concept stocks fell across the board. As of press release, Yao Ming Kangde (02359) fell 6.47% to 36.15 yuan; Gloria Ying (06821) fell 5.33% to 63.05 yuan; Kanglong Chemical (03759) fell 4.96% to HK$9.96.
Gloria Ying (06821) plans to invest 300 million yuan to establish a biomedical innovation and synthetic biology industry investment fund with Haihe Fund, Eco-City State-owned Assets, etc.
Gloria Ying (06821) announced that in order to seize the booming development opportunities in the domestic and foreign innovative drug markets, by investing in specialized students...
A subsidiary of Gloria Incorporated (06821.HK) and CNBC Hengze jointly set up a fund
Gelonghui, April 30, 丨 Gloria Ying (06821.HK) announced that on April 29, 2024, Gloria Life Science Technology (a wholly-owned subsidiary of the company, as limited partner) signed a partnership agreement with CITIC Hengze (as general partner), Haizunchuang Enterprise Management (as general partner), Haihe Industrial Fund (as limited partner) and Tianjin Eco-City (as limited partner) to jointly establish a fund to invest in innovative biopharmaceuticals, synthetic biology and other industries in the future. According to the partnership agreement, the total amount of capital pledged by the fund is RMB 754 million, of which (i) CNBC Hengze will
Asymchem Laboratories (Tianjin) Co., Ltd. Recorded A 25% Miss On Revenue: Analysts Are Revisiting Their Models
It's been a good week for Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) shareholders, because the company has just released its latest first-quarter results, and the shares gained 5.7% to CN
Analysis
Price Target
No Data
